Pfizer Inc Stock Price Prediction
| PFE Stock | USD 25.13 0.19 0.76% |
Oversold Vs Overbought
35
Oversold | Overbought |
Quarterly Earnings Growth (0.98) | EPS Estimate Next Quarter 0.66 | EPS Estimate Current Year 2.9286 | EPS Estimate Next Year 2.8982 | Wall Street Target Price 32.5483 |
Using Pfizer hype-based prediction, you can estimate the value of Pfizer Inc from the perspective of Pfizer response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Pfizer using Pfizer's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Pfizer using crowd psychology based on the activity and movement of Pfizer's stock price.
Pfizer Short Interest
A significant increase or decrease in Pfizer's short interest from the previous month could be a good indicator of investor sentiment towards Pfizer. Short interest can provide insight into the potential direction of Pfizer stock and how bullish or bearish investors feel about the market overall.
200 Day MA 28.1217 | Short Percent 0.0109 | Short Ratio 1.83 | Shares Short Prior Month 67.6 M | 50 Day MA 28.3592 |
Pfizer Inc Hype to Price Pattern
Investor biases related to Pfizer's public news can be used to forecast risks associated with an investment in Pfizer. The trend in average sentiment can be used to explain how an investor holding Pfizer can time the market purely based on public headlines and social activities around Pfizer Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Pfizer's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Pfizer.
Pfizer Implied Volatility | 1.47 |
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Pfizer to buy its stock at a price that has no basis in reality. In that case, they are not buying Pfizer because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pfizer after-hype prediction price | USD 24.93 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Pfizer contract
Based on the Rule 16, the options market is currently suggesting that Pfizer Inc will have an average daily up or down price movement of about 0.0919% per day over the life of the 2024-11-22 option contract. With Pfizer trading at USD 25.13, that is roughly USD 0.0231 . If you think that the market is fully incorporating Pfizer's daily price movement you should consider acquiring Pfizer Inc options at the current volatility level of 1.47%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Pfizer |
Pfizer After-Hype Price Prediction Density Analysis
As far as predicting the price of Pfizer at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pfizer or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pfizer, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pfizer Estimiated After-Hype Price Volatility
In the context of predicting Pfizer's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pfizer's historical news coverage. Pfizer's after-hype downside and upside margins for the prediction period are 23.56 and 26.30, respectively. We have considered Pfizer's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pfizer is very steady at this time. Analysis and calculation of next after-hype price of Pfizer Inc is based on 3 months time horizon.
Pfizer Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pfizer, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.18 | 1.37 | 0.01 | 0.02 | 8 Events / Month | 5 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
25.13 | 24.93 | 0.04 |
|
Pfizer Hype Timeline
On the 21st of November Pfizer Inc is traded for 25.13. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.02. Pfizer is forecasted to decline in value after the next headline, with the price expected to drop to 24.93. The average volatility of media hype impact on the company price is over 100%. The price depreciation on the next news is expected to be -0.04%, whereas the daily expected return is at this time at -0.18%. The volatility of related hype on Pfizer is about 1085.15%, with the expected price after the next announcement by competition of 25.11. About 68.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 1.53. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Pfizer Inc has Price/Earnings To Growth (PEG) ratio of 0.18. The entity last dividend was issued on the 8th of November 2024. The firm had 1054:1000 split on the 17th of November 2020. Considering the 90-day investment horizon the next forecasted press release will be in about 8 days. Check out Pfizer Basic Forecasting Models to cross-verify your projections.Pfizer Related Hype Analysis
Having access to credible news sources related to Pfizer's direct competition is more important than ever and may enhance your ability to predict Pfizer's future price movements. Getting to know how Pfizer's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pfizer may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| JNJ | Johnson Johnson | (1.31) | 6 per month | 0.00 | (0.19) | 1.36 | (1.42) | 3.25 | |
| SCRYX | Small Cap Core | 0.00 | 0 per month | 0.96 | 0.01 | 2.39 | (1.69) | 7.88 | |
| FRHC | Freedom Holding Corp | 0.57 | 8 per month | 1.13 | 0.24 | 4.02 | (2.40) | 7.38 | |
| GFL | Gfl Environmental Holdings | (0.41) | 8 per month | 1.36 | 0.02 | 2.97 | (2.29) | 7.37 | |
| RGAGX | Growth Fund Of | (0.97) | 1 per month | 0.91 | 0.02 | 1.34 | (1.66) | 4.40 | |
| SVII | Spring Valley Acquisition | (0.06) | 2 per month | 0.39 | (0.17) | 0.44 | (0.53) | 4.77 | |
| GFI | Gold Fields Ltd | (0.18) | 11 per month | 0.00 | (0.08) | 4.52 | (5.41) | 14.93 | |
| KNF | Knife River | 1.35 | 8 per month | 1.88 | 0.15 | 4.01 | (2.46) | 12.96 |
Pfizer Additional Predictive Modules
Most predictive techniques to examine Pfizer price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pfizer using various technical indicators. When you analyze Pfizer charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pfizer Predictive Indicators
The successful prediction of Pfizer stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pfizer Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pfizer based on analysis of Pfizer hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pfizer's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pfizer's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Dividend Yield | 0.0264 | 0.0313 | 0.0569 | 0.0598 | Price To Sales Ratio | 4.07 | 2.86 | 2.78 | 4.61 |
Story Coverage note for Pfizer
The number of cover stories for Pfizer depends on current market conditions and Pfizer's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pfizer is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pfizer's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Pfizer Short Properties
Pfizer's future price predictability will typically decrease when Pfizer's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pfizer Inc often depends not only on the future outlook of the potential Pfizer's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pfizer's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.7 B | |
| Cash And Short Term Investments | 12.7 B |
Complementary Tools for Pfizer Stock analysis
When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |